Tumors induce coordinate growth of artery, vein, and lymphatic vessel triads

BMC Cancer

Alanna Ruddell²  Alexandra Croft²  Karen Kelly-Spratt¹  Momoko Furuya¹  Christopher J Kemp¹ 

[1] Fred Hutchinson Cancer Research Center, Seattle, WA, USA

[2] Department of Comparative Medicine, University of Washington School of Medicine, 1959 NE Pacific St., Box 357190, Seattle, WA 98195, USA

关键词: Blood vessel;    Angiogenesis;    Lymphatic vessel;    Lymphangiogenesis;    Carcinoma;    Melanoma;   

Others  :  858804
DOI  :  10.1186/1471-2407-14-354

 received in 2013-12-03, accepted in 2014-05-16,  发布年份 2014

【 摘 要 】

Background

Tumors drive blood vessel growth to obtain oxygen and nutrients to support tumor expansion, and they also can induce lymphatic vessel growth to facilitate fluid drainage and metastasis. These processes have generally been studied separately, so that it is not known how peritumoral blood and lymphatic vessels grow relative to each other.

Methods

The murine B16-F10 melanoma and chemically-induced squamous cell carcinoma models were employed to analyze large red-colored vessels growing between flank tumors and draining lymph nodes. Immunostaining and microscopy in combination with dye injection studies were used to characterize these vessels.

Results

Each peritumoral red-colored vessel was found to consist of a triad of collecting lymphatic vessel, vein, and artery, that were all enlarged. Peritumoral veins and arteries were both functional, as detected by intravenous dye injection. The enlarged lymphatic vessels were functional in most mice by subcutaneous dye injection assay, however tumor growth sometimes blocked lymph drainage to regional lymph nodes. Large red-colored vessels also grew between benign papillomas or invasive squamous cell carcinomas and regional lymph nodes in chemical carcinogen-treated mice. Immunostaining of the red-colored vessels again identified the clustered growth of enlarged collecting lymphatics, veins, and arteries in the vicinity of these spontaneously arising tumors.

Conclusions

Implanted and spontaneously arising tumors induce coordinate growth of blood and lymphatic vessel triads. Many of these vessel triads are enlarged over several cm distance between the tumor and regional lymph nodes. Lymphatic drainage was sometimes blocked in mice before lymph node metastasis was detected, suggesting that an unknown mechanism alters lymph drainage patterns before tumors reach draining lymph nodes.

【 授权许可】

   
2014 Ruddell et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Gray H: Anatomy of the human body. Philadelphia: Lea and Febiger; 1918.
• [2]Sabin FR: The lymphatic system in human embryos, with a consideration of the morphology of the system as a whole. Am J Anat 1909, 9:43-91.
• [3]Kume T: Specification of arterial, venous, and lymphatic endothelial cells during embryonic development. Histol Histopathol 2010, 25:637-646.
• [4]Adams RH, Eichmann A: Axon guidance molecules in vascular patterning. Cold Spring Harb Perspect Biol 2010, 2:a001875.
• [5]Adams RH, Alitalo K: Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007, 8:464-478.
• [6]Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
• [7]Folkman J, Ingber D: Inhibition of angiogenesis. Semin Cancer Biol 1992, 3:89-96.
• [8]Folkman J: The role of angiogenesis in tumor growth. Semin Cancer Biol 1992, 3:65-71.
• [9]Nagy JA, Chang SH, Dvorak AM, Dvorak HF: Why are tumour blood vessels abnormal and why is it important to know? Br J Cancer 2009, 100:865-869.
• [10]Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG, Orci L, Alitalo K, Christofori G, Pepper MS: Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 2001, 20:672-682.
• [11]Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M: Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001, 7:192-198.
• [12]Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, Jackson DG, Nishikawa S, Kubo H, Achen MG: VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 2001, 7:186-191.
• [13]Wiig H, Swartz MA: Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer. Physiol Rev 2012, 92:1005-1060.
• [14]Hagendoorn J, Tong R, Fukumura D, Lin Q, Lobo J, Padera TP, Xu L, Kucherlapati R, Jain RK: Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis. Cancer Res 2006, 66:3360-3364.
• [15]Cao Y: Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 2005, 5:735-743.
• [16]Shayan R, Achen MG, Stacker SA: Lymphatic vessels in cancer metastasis: bridging the gaps. Carcinogenesis 2006, 27:1729-1738.
• [17]Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM: Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 1988, 133:95-109.
• [18]Hilmas DE, Gillette EL: Morphometric analyses of the microvasculature of tumors during growth and after x-irradiation. Cancer 1974, 33:103-110.
• [19]Scavelli C, Vacca A, Di Pietro G, Dammacco F, Ribatti D: Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia 2004, 18:1054-1058.
• [20]Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald DM: Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000, 156:1363-1380.
• [21]Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, Munn LL, Jain RK: Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002, 296:1883-1886.
• [22]Fidler IJ: Selection of successive tumor lines for metastasis. Nat New Biol 1973, 242:148-149.
• [23]Ruddell A, Harrell MI, Furuya M, Kirschbaum SB, Iritani BM: B lymphocytes promote lymphogenous metastasis of lymphoma and melanoma. Neoplasia 2011, 13:748-757.
• [24]Harrell MI, Iritani BM, Ruddell A: Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol 2007, 170:774-786.
• [25]Giavazzi R, Garofalo A: B16 Melanoma Metastasis. In Methods in Molecular Medicine. Volume 58. 1st edition. Edited by Brooks SA, Schumacher U. Totowa, New Jersey: Humana Press, Inc; 2001:223-229.
• [26]Quintanilla M, Brown K, Ramsden M, Balmain A: Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 1986, 322:78-80.
• [27]Fidler IJ: Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res 1975, 35:218-224.
• [28]Kelly-Spratt KS, Gurley KE, Yasui Y, Kemp CJ: p19Arf supports growth, malignant conversion, and metastasis of Ha-ras driven squamous cell carcinomas through p53 dependent and independent pathways. PLoS Biol 2004, 2:1138-1149.
• [29]Kemp CJ, Donehower LA, Bradley A, Balmain A: Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 1993, 4:813-822.
• [30]Farr A, Nelson A, Hosier S, Kim A: A novel cytokine-responsive cell surface glycoprotein defines a subset of medullary thymic epithelium in situ. J Immunol 1993, 150:1160-1171.
• [31]Tilney NL: Patterns of lymphatic drainage in the adult laboratory rat. J Anat 1971, 109:369-383.
• [32]Harrell MI, Iritani BM, Ruddell A: Lymph node mapping in the mouse. J Immunol Methods 2008, 332:170-174.
• [33]Ruddell A, Harrell MI, Minoshima S, Maravilla KR, Iritani BM, White SW, Partridge SC: Dynamic contrast-enhanced magnetic resonance imaging of tumor-induced lymph flow. Neoplasia 2008, 10:706-713.
• [34]Baluk P, Fuxe J, Hashizume H, Romano T, Lashnits E, Butz S, Vestweber D, Corada M, Molendini C, Dejana E, McDonald DM: Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 2007, 204:2349-2362.
• [35]Furuya M, Kirschbaum SB, Paulovich A, Pauli BU, Zhang H, Alexander JS, Farr AG, Ruddell A: Lymphatic endothelial murine chloride channel calcium-activated 1 is a ligand for leukocyte LFA-1 and Mac-1. J Immunol 2010, 185:5769-5777.
• [36]Ruddell A, Mezquita P, Brandvold KA, Farr A, Iritani BM: B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis. Am J Pathol 2003, 163:2233-2245.
• [37]Makinen T, Adams RH, Bailey J, Lu Q, Ziemiecki A, Alitalo K, Klein R, Wilkinson GA: PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev 2005, 19:397-410.
• [38]van Amerongen MJ, Molema G, Plantinga J, Moorlag H, van Luyn MJ: Neovascularization and vascular markers in a foreign body reaction to subcutaneously implanted degradable biomaterial in mice. Angiogenesis 2002, 5:173-180.
• [39]Wigle JT, Harvey N, Detmar M, Lagutina I, Grosveld G, Gunn MD, Jackson DG, Oliver G: An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 2002, 21:1505-1513.
• [40]Hallmann R, Mayer DN, Berg EL, Broermann R, Butcher EC: Novel mouse endothelial cell surface marker is suppressed during differentiation of the blood brain barrier. Dev Dyn 1995, 202:325-332.
• [41]Norrmen C, Ivanov KI, Cheng J, Zangger N, Delorenzi M, Jaquet M, Miura N, Puolakkainen P, Horsley V, Hu J, Augustin HG, Yla-Herttuala S, Alitalo K, Petrova TV: FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J Cell Biol 2009, 185:439-457.
• [42]Alitalo K: The lymphatic vasculature in disease. Nat Med 2011, 17:1371-1380.
• [43]Rafii S, Lyden D, Benezra R, Hattori K, Heissig B: Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2002, 2:826-835.
• [44]Zumsteg A, Baeriswyl V, Imaizumi N, Schwendener R, Ruegg C, Christofori G: Myeloid cells contribute to tumor lymphangiogenesis. PLoS One 2009, 4:e7067.
• [45]Karnezis T, Shayan R, Caesar C, Roufail S, Harris NC, Ardipradja K, Zhang YF, Williams SP, Farnsworth RH, Chai MG, Rupasinghe TW, Tull DL, Baldwin ME, Sloan EK, Fox SB, Achen MG, Stacker SA: VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell 2012, 21:181-195.
• [46]Risau W: Mechanisms of angiogenesis. Nature 1997, 386:671-674.
• [47]Saharinen P, Tammela T, Karkkainen MJ, Alitalo K: Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 2004, 25:387-395.
• [48]Cleaver O, Melton DA: Endothelial signaling during development. Nat Med 2003, 9:661-668.
• [49]Oliver G: Lymphatic vasculature development. Nat Rev Immunol 2004, 4:35-45.
• [50]Harvey NL, Oliver G: Choose your fate: artery, vein or lymphatic vessel? Curr Opin Genet Dev 2004, 14:499-505.
• [51]Simons M, Eichmann A: Physiology. Lymphatics are in my veins. Science 2013, 341:622-624.
• [52]Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992, 127:392-399.
• [53]Cheng G, Kurita S, Torigian DA, Alavi A: Current status of sentinel lymph-node biopsy in patients with breast cancer. Eur J Nucl Med Mol Imaging 2011, 38:562-575.
• [54]Spillane AJ, Brennan ME: Accuracy of sentinel lymph node biopsy in large and multifocal/multicentric breast carcinoma–a systematic review. Eur J Surg Oncol 2011, 37:371-385.
• [55]Testori A, De Salvo GL, Montesco MC, Trifiro G, Mocellin S, Landi G, Macripo G, Carcoforo P, Ricotti G, Giudice G, Picciotto F, Donner D, Di Filippo F, Soteldo J, Casara D, Schiavon M, Vecchiato A, Pasquali S, Baldini F, Mazzarol G, Rossi CR: Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI). Ann Surg Oncol 2009, 16:2018-2027.
• [56]Kwon S, Sevick-Muraca EM: Functional lymphatic imaging in tumor-bearing mice. J Immunol Methods 2010, 360:167-172.
• [57]Proulx ST, Luciani P, Christiansen A, Karaman S, Blum KS, Rinderknecht M, Leroux JC, Detmar M: Use of a PEG-conjugated bright near-infrared dye for functional imaging of rerouting of tumor lymphatic drainage after sentinel lymph node metastasis. Biomaterials 2013, 34:5128-5137.
• [58]Scoggins CR, Martin RC, Ross MI, Edwards MJ, Reintgen DS, Urist MM, Gershenwald JE, Sussman JJ, Dirk Noyes R, Goydos JS, Beitsch PD, Ariyan S, Stromberg AJ, Hagendoorn LJ, McMasters KM: Factors associated with false-negative sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol 2010, 17:709-717.
• [59]Tammela T, Saaristo A, Holopainen T, Yla-Herttuala S, Andersson LC, Virolainen S, Immonen I, Alitalo K: Photodynamic ablation of lymphatic vessels and intralymphatic cancer cells prevents metastasis. Sci Transl Med 2011, 3:69ra11.
• [60]Lohela M, Bry M, Tammela T, Alitalo K: VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 2009, 21:154-165.
• [61]Baldwin ME, Stacker SA, Achen MG: Molecular control of Lymphangiogenesis. Bioessays 2002, 24:1030-1040.
• [62]Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Detmar MJ, Lawitts JA, Benjamin L, Tan X, Manseau EJ, Dvorak AM, Dvorak HF: Vascular permeability factor/vascular endothelial growth factor induces Lymphangiogenesis as well as Angiogenesis. J Exp Med 2002, 196:1497-1506.
• [63]Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, Jauch KW, Geissler EK: Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 2002, 8:128-135.
• [64]Ruddell A, Kelly-Spratt KS, Furuya M, Parghi SS, Kemp CJ: p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis. Oncogene 2008, 27:3145-3155.